- Strengthening Intellectual Property for Sublingual Delivery of Apomorphine to Treat OFF Episodes in Parkinson`s Disease Patients - TORONTO and WARREN, N.J., April 04, 2016 (GLOBE NEWSWIRE) ...

MonoSol Rx is on a roll. During the span of a month this summer, the tiny Warren-based company announced that two of its drugmaker partners had received regulatory approval to sell reformulated ...

Specialty pharmaceutical company will receive an exclusive license to use MonoSol Rx s drug-delivery technology.Adams Respiratory Therapeutics Inc. (Nasdaq: ARxT) has entered into an agreement with ...

MonoSol Rx said today it has closed a $10 million private loan from financial services firm White Oak Partners.MonoSol Rx said today it has closed a $10 million private loan from financial services ...

WARREN, N.J., April 25, 2011 /PRNewswire/ -- MonoSol Rx, LLC ("MonoSol Rx"), the developer of PharmFilm® drug delivery technology, today announced that the Company has entered into a development and ...

MonoSol, a drug delivery developer based in Warren, N.J., has received $20 million in financing, which includes the conversion of a year-old $10 million bridge loan. Ed Bass Group led the financing ...

WARREN, N.J., Feb. 21 MonoSol Rx, a drug delivery companyspecializing in dissolving thin film pharmaceutical products, today announcedthat it has successfully completed a pilot clinical study for its ...

Lupin’s U.S. subsidiary has picked up the rights to MonoSol Rx’s PharmFilm drug delivery technology, which is a dissolvable film for patients who have difficulty swallowing pills. PharmFilm is a quick ...

TORONTO, ONTARIO and WARREN, NEW JERSEY--(Marketwired - Apr 4, 2016) - Cynapsus Therapeutics Inc. ("Cynapsus" or the "Company") (CYNA)(CTH.TO), and MonoSol Rx LLC ("MonoSol Rx") today announced that ...